鱼皮敷料与Suprathel在深度部分厚度烧伤中的长期瘢痕质量个体内比较
这项前瞻性个体内研究纳入21例手和足深度部分厚度烧伤患者,经Nexobrid酶性清创后,在可比烧伤区域分别使用Kerecis®和Suprathel®。随访至12个月时,客观测量显示两组在红斑和总体弹性上有显著差异,Kerecis®结果相对更优;VSS和POSAS观察者量表显示Kerecis®组瘢痕高度和柔韧性显著改善,但POSAS患者量表无显著差异。
要点
- 酶性清创后深度部分厚度烧伤使用Kerecis®或Suprathel®均可获得满意长期瘢痕结果。
- 12个月时Kerecis®在红斑和总体弹性等客观指标上相对更优。
- VSS和POSAS观察者量表显示Kerecis®组瘢痕高度和柔韧性显著改善,患者自评无显著差异。
核心结论
- 两种敷料在酶性清创后的深度部分厚度烧伤中均提供满意的长期瘢痕结果,Kerecis®在部分选定参数上呈现更生理性瘢痕特征的趋势。
研究设计与样本
- 前瞻性个体内比较研究,纳入21例手和足深度部分厚度烧伤患者,经Nexobrid®酶性清创后,在可比烧伤区域分别使用Kerecis®和Suprathel®。
主要发现
- 12个月随访时,客观测量显示红斑和总体弹性存在显著差异,Kerecis®结果相对更优。
- VSS和POSAS观察者量表显示Kerecis®组瘢痕高度和柔韧性显著改善。
- POSAS患者量表未发现显著差异。
关键数值与推荐
- 瘢痕评估时间点为治疗后3、6、12个月。
- 客观参数包括皮肤色素沉着、弹性、经表皮水分丢失和氧饱和度。
- 主观评估使用POSAS和VSS。
临床怎么用
- 在深度部分厚度烧伤酶性清创后,可考虑将Kerecis®作为敷料选择之一,以期在红斑、弹性和观察者评估的瘢痕高度与柔韧性方面获得更优结果。
- 患者自评未见显著差异,临床决策需结合患者偏好与个体情况。
局限性
- 样本量较小(21例),需进一步以患者为中心的研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deep dermal burns pose a high risk for long-term functional and esthetic impairments. The choice of wound dressing following enzymatic debridement plays a critical role in modulating the healing response and scar formation. While both Kerecis® and Suprathel® have demonstrated clinical safety and efficacy, comparative long-term data remain limited. Kerecis®, being associated with accelerated wound healing in previous studies, was compared to Suprathel® in this study to evaluate functional and esthetic scar outcomes using an intraindividual study design. This prospective, intraindividual study included 21 patients with deep dermal burns of the hands and feet, who underwent enzymatic debridement using Nexobrid®. Each patient received treatment with both Kerecis® and Suprathel® on comparable burn areas, ensuring consistency in the comparison. Scar outcomes were evaluated at 3-, 6-, and 12-month post-treatment. Objective parameters such as skin pigmentation, elasticity, transepidermal water loss, and oxygen saturation were measured. Additionally, subjective esthetic, clinical, and functional parameters were assessed using the Patient and Observer Scar Assessment Scale (POSAS) and the Vancouver Scar Scale (VSS). At the 12-month follow-up, objective measurements demonstrated significant differences in erythema and gross elasticity, with Kerecis® exhibiting comparatively favorable outcomes. Subjective analyses indicated a significantly improved scar height and pliability for the Kerecis® group in the VSS and the POSAS observer scale. However, no significant differences were found in the POSAS Patient Scale. Both dressings provide satisfactory long-term scar outcomes in enzymatically debrided deep dermal burns, with Kerecis® showing trends toward more physiological scar characteristics in selected parameters, warranting further patient-centered research.
引用
- Heitzmann W, Enzmann J, von Kohout M, et al. Fish Skin (Kerecis Omega 3 Wound®) vs Suprathel® in Deep Dermal Burns: An Intraindividual Comparison of Long-Term Scar Quality. J Burn Care Res. 2026. PMID: 41744053. doi:10.1093/jbcr/irag034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。